OBJECTIVES: To evaluate the efficacy of treatments for aqueous misdirection syndrome and explore possible risk factors influencing prognosis. METHODS: Data including demographics, initial clinical characteristics and ocular outcomes at follow-up were collected for patients treated for aqueous misdirection syndrome. Main outcome measures were: best-corrected visual acuity (BCVA); intraocular pressure (IOP); number of antiglaucoma medications; recurrence; complications. RESULTS: Data were available for 50 patients (57 eyes). Final mean BCVA improved significantly and correlated with baseline BCVA (mean follow-up, 34.47 ± 28.65 months). Final mean IOP and mean number of antiglaucoma medications were significantly reduced. Treatment failure rates were higher in patients with significantly higher IOP at baseline and/or shorter axial length. Following pars plana vitrectomy (PPV), recurrence occurred in two of 10 pseudophakic and one of 40 phakic eyes; complications were observed in 12/50 eyes (choroidal detachment, corneal decompensation, retinal detachment, vitreous haemorrhage, hyphaema). CONCLUSIONS: PPV and laser treatments, augmented by pharmacotherapy, were effective in treating aqueous misdirection syndrome. Surgical intervention should be undertaken early in eyes with higher baseline IOP and/or shorter axial length. Total vitrectomyzonulectomy-iridectomy is a potential approach for recalcitrant cases.
Introduction
Aqueous misdirection syndrome (also known as malignant glaucoma, ciliary block glaucoma), which was initially described by Von Graefe in 1869, 1 is a rare but serious condition, classically occurring in eyes with angle-closure glaucoma. It is characterized by a uniform flattening of the anterior chamber both centrally and peripherally, the presence of a patent iridotomy, and the absence of choroidal detachment, suprachoroidal haemorrhage and overfiltration of bleb. Intraocular pressure (IOP) is usually, but not always, elevated. Topical miotics, 2 blunt trauma, 3 intraocular inflammation, 4 cataract extraction, 5, 6 laser iridotomy, 7 -9 presence of large optic intraocular lenses (IOL), 10 retinal conditions C Zhou, S Qian, J Yao et al. Aqueous misdirection syndrome (e.g. cicatricial retinopathy, 11 central retinal venous occlusion 12 ) short axial length and hyperplastic ciliary processes 13 can predispose patients to, or even worsen, this condition.
The pathophysiology of aqueous misdirection syndrome is incompletely understood, but a key mechanism is believed to be abnormal anatomical relationships at the level of the ciliary processes, lens equator and anterior vitreous hyaloid interface. 14 This abnormal anatomy leads to a misdirection of aqueous flow into the vitreous cavity, and the progressive vitreal swelling pushes the iris-lens diaphragm forward, further blocking the normal pathway for the aqueous flow. The resulting shallow anterior chamber, with anterior displacement of the peripheral iris into the angle, creates a further cycle of angle-closure glaucoma. In addition, an inherent permeability defect in the anterior vitreous body (as well as choroidal expansion) may also play a role in the pathophysiological process. 15 The management of aqueous misdirection syndrome should be sequential and individualized according to the anatomy of the presenting eye. The goal of treatment is to establish a communication between the vitreous cavity and the anterior chamber, with the aim of restoring aqueous flow. 16 Between 0% and 50% of patients with aqueous misdirection syndrome respond to pharmacotherapy, 17, 18 which includes a triad of intensive cycloplegics, aggressive aqueous suppressants (specifically, α 2 -adrenergic agonists, β-adrenergic antagonists, carbonic anhydrase inhibitors) and hyperosmotic agents. For patients who are refractory to pharmacotherapy, the following types of laser treatments are used: neodymium: yttrium-aluminium-garnet (Nd:YAG) laser capsulotomy; 19 Nd:YAG laser hyaloidotomy; 20 trans-scleral cyclodiode laser photocoagulation. 21 Pars plana vitrectomy (PPV) is generally reserved for patients who are not amenable to pharmacotherapy or laser therapy.
In clinical studies, most patients have been shown to achieve resolution of symptoms of aqueous misdirection syndrome, especially since the development of a series of novel laser and surgical techniques, including vitrectomyphacoemulsification-vitrectomy, 22 the combination of PPV, hyaloidozonulectomy and peripheral iridectomy (and phacoemulsification, if applicable) 23 and total vitrectomy-iridectomy-zonulectomy. 18 Most studies have, however, only included limited numbers of patients and relatively short follow-up periods. To the best of our knowledge, no publications have examined the risk factors that influence the prognosis of aqueous misdirection syndrome. Furthermore, there appears to be little information available on the treatment of recurrent (or recalcitrant) cases. The present study aimed to evaluate the prognosis and risk factors for aqueous misdirection syndrome, and to explore more effective ways of treating patients. The diagnosis of aqueous misdirection syndrome was established, based on: (i) presence of a central and peripheral shallow or flat anterior chamber; (ii) elevated IOP C Zhou, S Qian, J Yao et al.
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(≥ 21 mmHg); (iii) typical anatomical features indicated by ultrasound biomicroscopy, such as anterior rotation of the ciliary body and absence of a posterior chamber. Eyes with pupillary block, suprachoroidal haemorrhage and postoperative bleb leakage were excluded from the study.
Prior to surgery, an ocular history had been obtained for all participants. Patients with aqueous misdirection syndrome had started treatment with standard regimens of intensive pharmacotherapy, which included cycloplegics (1.0% atropine three times daily), aqueous suppressants (such as α 2adrenergic agonists, β-adrenergic antagonists, carbonic anhydrase inhibitors), hyperosmotic agents and glucocorticosteroids (1.0% dexamethasone three or four times daily). Eyes that did not respond to a trial period (typically 4 -8 days) with these pharmacotherapy regimens subsequently underwent surgical and/or laser treatment.
Letters and telephone calls were made to all patients who met the above criteria, to ask if they would volunteer to be included in the present follow-up study. The research protocol was approved by the Institutional Review Board of the Eye & ENT Hospital of Fudan University, and verbal informed consent was obtained from each patient. The study adhered to the tenets of the Declaration of Helsinki.
STUDY DESIGN
Baseline information
Baseline information obtained from the patients' medical records (described above), together with information on surgical complications and aqueous misdirection syndrome recurrence (denoted by relapsed aqueous misdirection after PPV), were reviewed by C.Z., who discussed the findings with S.Q. if necessary. This information was recorded. Information in the patients' notes relating to pretreatment IOP, best-corrected visual acuity (BCVA), cup-to-disc ratio and mean defect of the central 30° visual field was also recorded, together with IOP and BCVA results, prior to hospital discharge.
Follow-up evaluations
Each patient underwent a comprehensive ophthalmic evaluation with respect to the affected eye(s), which included: (i) BCVA, using a Snellen visual acuity chart; (ii) IOP measurement, using a Goldmann applanation tonometer (Haag-Streit, Koeniz, Switzerland);
(iii) complete ocular examination, with slit-lamp biomicroscopy and direct and indirect fudus ophthalmoscopy (slit-lamp photographs were taken, if necessary); (iv) central 30°v isual field evaluation using an automated static perimeter (Octopus ® 900; Haag-Streit); and (v) ultrasound biomicroscopy (BME-300W; Meda, Tianjin, China). All subjective evaluations were performed by the same surgeon (S.Q.). These evaluations included complete ocular examination, with slit-lamp biomicroscopy and direct and indirect fundus ophthalmoscopy.
Treatment success was defined as: (i) IOP < 21 mmHg with or without glaucoma medication; (ii) formation of an anterior chamber; (iii) BCVA greater than no light perception.
STATISTICAL ANALYSES
Data were presented as mean ± SD or n patients. Statistical analyses were performed using STATA ® software, version 10.0 (StataCorp LP, College Station, TX, USA). Student's t-test and the Wilcoxon signedrank sum test were performed to compare variables before and after treatment. Spearman's correlation coefficient was used to determine the relationship between initial and final BCVA. Treatment success was C Zhou, S Qian, J Yao et al.
Aqueous misdirection syndrome
assessed using Kaplan-Meier analysis. Cox proportional hazards regression analysis was used to determine risk factors influencing the prognosis of eyes with aqueous misdirection syndrome. A P-value < 0.05 was considered to be statistically significant.
Results
DEMOGRAPHIC DATA
In total, 72 patients (80 eyes) met the study inclusion criteria; attempts were made to contact these patients by letter and telephone. There were 63 patients who responded voluntarily, of whom five subsequently died of other systemic diseases and a further eight dropped out for other reasons (including impaired mobility because of poor vision, loss of confidence in continuous treatments or poor economic status as a result of visual loss). Consequently, 50 patients (34 females; 16 males) were included in the follow-up study, with a total of 57 eyes available for evaluation. The mean age of patients at diagnosis of aqueous misdirection syndrome was 58.90 ± 11.38 years (range 35 -81 years) and the mean follow-up period was 34.47 ± 28.65 months.
CLINICAL CHARACTERISTICS
Comprehensive documentation relating to the follow-up criteria were obtained for almost all of the eyes (Table 1) , with the exception that some examination findings were unavailable for one eye that underwent enucleation as a result of the patient's intolerance to an exceptionally elevated IOP (75 mmHg).
Clinical features of the affected eyes are summarized in Table 1 . The time interval between the last ocular surgery and occurrence of aqueous misdirection syndrome symptoms differed greatly (between 1 day and 10 years), At baseline, BCVA ranged from light perception to 1.0: 14/57 (25%) eyes had nonambulatory vision (hand motion; Fig. 1 ). All patients had started treatment with standard regimens of intensive pharmacotherapy, as described in the Patients and Methods. At baseline, only five of 57 (9%) eyes responded to the trial period of pharmacotherapy; the remaining eyes had to undergo surgical and/or laser treatment subsequent to failure of pharmacotherapy regimens (Table 1) .
Following treatment, an anterior chamber was formed in all the affected eyes and IOP was lowered to < 21.00 mmHg (mean ± SD IOP 15.38 ± 4.44 mmHg) in a mean ± SD period of 11.79 ± 6.71 days (range 3 -27 days). The BCVA of all eyes at the last follow-up ranged from no light perception to 1.0; eight of the 56 (14%) eyes had nonambulatory vision.
Compared with baseline, the change in BCVA was statistically significant after treatment (P = 0.002; 56 eyes); 33/57 (58%) eyes had an improvement in BCVA ( Fig. 1 ). Spearman's correlation coefficient indicated that final BCVA was significantly associated with baseline BCVA (r = 0.289, P = 0.029; 56 eyes).
At the final follow-up, there was a significant reduction in mean ± SD IOP from baseline of 14.29 ± 13.97 mmHg (P < 0.001; 56 eyes). Since baseline IOP varied greatly between patients, the percentage IOP reduction was calculated for each patient to compensate for the variability; mean ± SD IOP reduction was 40.59% ± 31.15%. Nine of the 56 (16%) eyes had an elevated IOP (≥ 21.00 mmHg): four of these had a BCVA of no light perception. Compared with the baseline mean number of antiglaucoma medications used, there was a significant reduction in the use of such treatments at follow-up (P < 0.001). Mean cup-to-disc ratio was significantly greater at follow-up compared with baseline (P = 0.006; 56 eyes). There were no statistically significant 
RISK FACTORS INFLUENCING PROGNOSIS
Results of the Kaplan-Meier analysis for treatment success are shown in Fig. 4 and the Cox proportional hazards regression analysis of prognostic factors in aqueous misdirection syndrome are presented in Table 2 . Notably, eyes with higher baseline IOP and shorter axial length were significantly more likely to have a poor prognosis (P = 0.015 and P = 0.033, respectively). The risk factor of short axial length was confirmed by the increased risk shown by patients with nanophthalmos (n = 4; five eyes, P = 0.049).
COMPLICATIONS AND RECALCITRANT CASES
Of the 50 eyes that underwent PPV, 12 (24%) had postoperative complications (Table 3 ). combined with phacoemulsification was observed in one eye, and at a follow-up of 9 months this eye had developed total retinal detachment and the patient's BCVA was reduced to hand motion. This patient gave up further repair surgery. A persistently elevated IOP caused by bleb failure occurred in 12/50 (24%) eyes, four of which had a BCVA of no light perception at follow-up. Five eyes underwent an Ahmed tube shunt implantation and another seven eyes were treated with antiglaucoma medication.
In total, relapsed aqueous misdirection syndrome was reported in three of 50 (6%) eyes following PPV. One pseudophakic eye was relieved after repeat vitrectomy. The recurrence of aqueous misdirection syndrome in another pseudophakic eye with lens subluxation was resolved by complete vitrectomy-iridectomy-zonulectomy and by implanting an IOL into the ciliary groove. In one phakic eye, repeat vitrectomy combined with iridectomy and Nd:YAG laser capsuloctomy were consecutively performed, without significant deepening of the anterior chamber and reduction of the IOP. Finally, the combination of total vitrectomy and an Ahmed valve implantation was carried out, which resulted in the formation of the anterior chamber and an IOP of 14 mmHg.
Discussion
Aqueous misdirection syndrome remains one of the most challenging problems faced by ophthalmologists. Conventional pharmacotherapy and laser therapy are sometimes insufficient to resolve this condition, and most patients have to undergo surgical treatment to re-establish communication between the anterior chamber and the vitreous cavity. The present study reviewed data for 57 eyes with aqueous misdirection syndrome and found that PPV with laser treatments augmented by pharmacotherapy were effective in relieving this condition.
The time interval between the last ocular surgery and occurrence of aqueous misdirection syndrome symptoms differed greatly (between 1 day and 10 years), indicating that the last surgery was not necessarily a precipitating event. Eyes with higher baseline IOP and/or shorter axial length were more likely to have a poor prognosis. Moreover, total vitrectomyzonulectomy-iridectomy is probably a novel surgical approach for the treatment of recalcitrant or recurrent cases.
In agreement with previous studies, 24,25 the present study suggested that shorter axial length may predispose (or even worsen) aqueous misdirection syndrome. C Zhou, S Qian, J Yao et al.
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The baseline mean ± SD axial length in the present study was only 21.56 ± 1.60 mm and, for this type of eye undergoing phacoemulsification and IOL implantation, we recommend an IOL of smaller diameter, which can be preoperatively tailored by panoramic ultrasound biomicroscopy. Furthermore, eyes with a higher baseline IOP had the worse prognosis, presumably because corneal decompensation and severe irreversible optic nerve injury are more likely to occur under conditions of high IOP, especially when irido-corneal touch has already occurred. Substantial corneal oedema necessitates early surgical intervention as it compromises both surgical and laser therapies; in such circumstances, lensectomy is generally recommended. 26 Sharma et al. 22 reported vitrectomyphacoemulsification-vitrectomy to be effective in treating phakic eyes with aqueous misdirection syndrome, as the first step of core vitrectomy tends to reduce the forward pressure and deepen the shallow/flat anterior chamber, thereby providing more space for phacoemulsification and preventing corneal endothelial injuries. Moreover, elevated pressure in the vitreous cavity pushes the iris-lens diaphragm forward, further blocking the filtration channel created by trabeculectomy. Consequently, bleb failure is more frequently induced in patients with aqueous misdirection syndrome than in those without this condition.
There have been various reports regarding recurrence of aqueous misdirection syndrome in phakic and pseudophakic eyes. In some studies, the recurrence rate in phakic eyes that underwent PPV combined with phacoemulsification was 0% 26, 27 and 17%, 28 and in pseudophakic eyes that underwent PPV was 0%, 16 10% 26,29 and 33%; 28 however, phakic eyes that underwent PPV only were more likely (75%, 28 26% 26 and 50% 29 ) to experience recurrence. Recurrent aqueous misdirection syndrome was observed in two of 10 (20%) pseudophakic eyes after PPV and one of 40 (2.5%) phakic eyes that underwent PPV combined with phacoemulsification or lensectomy, in the present study. Failure of PPV in patients with aqueous misdirection syndrome may be related to three aspects. First, complete vitreous base shaving is difficult to obtain. Inadequate pupil dilation compromises visualization of the anterior vitreous and, for eyes that do not respond well to cycloplegics, pupil enlargement should be facilitated by iris hooks, sphincterotomies and posterior synechiolysis. 22 Furthermore, incomplete PPV is sometimes not evident until the patient stands up several days postoperatively, as the vitreous body moves anteriorly by gravity. Thus, vitreoretinal surgical expertise is needed to perform this type of surgery. Secondly, apart from carrying out an adequate PPV, zonulectomy combined with iridectomy should also be performed to create a definite channel between the vitreous cavity and the anterior chamber. Thirdly, the anterior rotation of the lens-iris diaphragm is intractable in patients with zonular abnormality, which is markedly typical in eyes with lens subluxation. 15 In this condition, ultrasound biomicroscopy can often be helpful because it shows the asymmetrical anterior chamber depths of the patient's eyes; for these patients, we recommend that total vitrectomy-iridectomy-zonulectomy is performed and that an IOL is implanted in the ciliary groove, to avoid an unstable endocapsular placement.
Failure of previous filtering surgery after resolution of aqueous misdirection syndrome has been reported. 26 31 suggested that combined vitrectomy and tube shunt implantation through the pars plana in pseudophakic eyes can prevent further recurrence and achieve long-term IOP control.
To the best of our knowledge, the series of 50 patients (57 eyes) with aqueous misdirection syndrome described in the present paper constitutes the largest report in this field, to date. A key drawback of this study was its retrospective, noncomparative nature; the extremely low incidence of aqueous misdirection syndrome 17 makes it difficult to gather data from a large number of patients. Moreover, the use of untreated control patients with aqueous misdirection syndrome would cause insurmountable ethical dilemmas. Another bias may relate to the registration of the follow-up cohort, because the patients were not consecutively recruited. Letters were sent and phone calls were made to all patients with aqueous misdirection syndrome who had attended the Department of Ophthalmology and Vision Science across the study period, and patients entered the follow-up study voluntarily. Some patients did not participate because of a poor prognosis (e.g. mobility difficulties caused by poor vision), loss of confidence in continuous treatments and poor economic status as a result of visual loss. It was also not possible to contact some patients. All of the above situations may have caused selection bias. These drawbacks would have had effects on the visual outcomes of this follow-up study. The strengths of the study were the relatively large number of patients and the fact that all subjective evaluations were performed by the same surgeon, which may have partially overcome the biases described.
In conclusion, performing an adequate vitrectomy (either complete PPV with vitreous base shaving or total vitrectomy) and establishing a definite channel between the vitreous cavity and the anterior chamber (i.e. zonulectomy combined with iridectomy) are two essential elements for attaining a cure in aqueous misdirection syndrome. Total vitrectomy-zonulectomy-iridectomy is, therefore, a potential novel surgical approach for the treatment of this condition, especially in recalcitrant and relapsed cases. As the present study involved only two eyes that underwent this type of procedure, there needs to be a larger series with long-term follow-up to validate this new surgical approach. In the light of our findings, early surgical interventions are recommended in patients with exceptionally elevated IOP and/or shorter axial length. Prospective, long-term, randomized, controlled studies are required to confirm these findings.
